Head and Neck Cancers Coverage from Every Angle
Advertisement
Advertisement

Sue Sun Yom, MD, PhD, on Quality of Life After Deintensified Radiotherapy for Oropharyngeal Cancer

Posted: Monday, September 30, 2019

Sue Sun Yom, MD, PhD, of the University of California, San Francisco, discusses whether recent trial data will have an impact on the use of reduced-dose intensity-modulated radiotherapy with or without cisplatin in treating patients with oropharyngeal cancer.

Advertisement
Advertisement


By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.